AlphaQuest’s Catalyst Pharmaceutical CPRX Stock Holding History

AlphaQuest’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-130,106	Closed	-$3.04M	–	469
2025 Q4	$3.04M	Buy	130,106 +66,169	+103%	+$1.47M	0.17%	97
2025 Q3	$1.26M	Buy	63,937 +30,817	+93%	+$634K	0.08%	337
2025 Q2	$719K	Buy	33,120 +24,531	+286%	+$579K	0.07%	437
2025 Q1	$208K	Sell	8,589 -35,327	-80%	-$796K	0.02%	973
2024 Q4	$917K	Buy	43,916 +6,582	+18%	+$141K	0.12%	267
2024 Q3	$742K	Buy	37,334 +37,231	+36,147%	+$690K	0.07%	496
2024 Q2	$1.59K	Sell	103 -133	-56%	-$2.07K	﹤0.01%	1364
2024 Q1	$3.76K	Buy	+236	New	+$3.56K	﹤0.01%	1103

Other funds holding CPRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM